N/A
N=21
Adapting an Evidence-based Intervention for Stigma-related Stress, Mental Health, and HIV Risk for MSM of Color in Small Urban Areas
HIV in MSM
Bottom Line
View on ClinicalTrials.gov: NCT03464422 ↗Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Aug 2021
Primary outcome: Primary: Depression — 22.10; 20.35 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ESTEEM conneCT (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Yale University
- Primary completion
- Aug 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Depression |
22.10; 20.35 | — |
| PRIMARY HIV Transmission Risk |
4.10; 8.29 | — |
| SECONDARY Overall Depression Severity and Impairment Scale |
11.00; 10.53 | — |
| SECONDARY Overall Anxiety Severity and Impairment Scale |
12.05; 11.88 | — |
| SECONDARY Brief Symptom Inventory |
2.12; 2.05 | — |
| SECONDARY Suicidal Ideation Attributes Scale |
4.33; 3.41 | — |
| SECONDARY Alcohol Use Disorders Identification Test |
16.90; 17.53 | — |
| SECONDARY Condom-use Self-Efficacy Questionnaire |
48.05; 49.24 | — |
| SECONDARY Sexual Compulsivity Scale |
18.38; 18.18 | — |
| SECONDARY Gay-Related Rejection Sensitivity Scale |
10.73; 9.92 | — |
| SECONDARY Self-concealment Scale |
2.15; 2.01 | — |
| SECONDARY Internalized Homophobia Scale |
1.53; 1.53 | — |
Summary
The purpose of this study is adapt an evidence-based intervention for stigma-related stress, mental health, and HIV risk for bay, bisexual, and other men who have sex with men (MSM) of color in small urban areas.
Eligibility Criteria
Inclusion Criteria
Participants must:
- Report anticipated 6-month residential stability in New Haven county
- Self-identify as a gay or bisexual man or report being a man who has had past-12-month sex with a man
- Self-identify as an ethnic or racial minority, including Black, African American, Caribbean American, Hispanic, and Latinx
- Speak fluent English
Exclusion Criteria
- Participants not meeting the inclusion criteria will not be eligible to participate.
Data sourced from ClinicalTrials.gov (NCT03464422). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.